Roivant Sciences Statistics
Total Valuation
ROIV has a market cap or net worth of $23.20 billion. The enterprise value is $18.77 billion.
Important Dates
The last earnings date was Wednesday, May 20, 2026, before market open.
| Earnings Date | May 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ROIV has 715.70 million shares outstanding. The number of shares has decreased by -4.35% in one year.
| Current Share Class | 715.70M |
| Shares Outstanding | 715.70M |
| Shares Change (YoY) | -4.35% |
| Shares Change (QoQ) | +16.56% |
| Owned by Insiders (%) | 24.23% |
| Owned by Institutions (%) | 75.49% |
| Float | 541.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2,808.22 |
| Forward PS | 373.83 |
| PB Ratio | 5.39 |
| P/TBV Ratio | 5.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2,272.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -7.83% and return on invested capital (ROIC) is -232.35%.
| Return on Equity (ROE) | -7.83% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -232.35% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 10.49% |
| Revenue Per Employee | $11,013 |
| Profits Per Employee | -$399,695 |
| Employee Count | 750 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ROIV has paid $133.33 million in taxes.
| Income Tax | 133.33M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +198.99% in the last 52 weeks. The beta is 1.14, so ROIV's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +198.99% |
| 50-Day Moving Average | 28.40 |
| 200-Day Moving Average | 21.77 |
| Relative Strength Index (RSI) | 69.95 |
| Average Volume (20 Days) | 6,149,742 |
Short Selling Information
The latest short interest is 27.06 million, so 3.78% of the outstanding shares have been sold short.
| Short Interest | 27.06M |
| Short Previous Month | 24.47M |
| Short % of Shares Out | 3.78% |
| Short % of Float | 4.99% |
| Short Ratio (days to cover) | 5.37 |
Income Statement
In the last 12 months, ROIV had revenue of $8.26 million and -$299.77 million in losses. Loss per share was -$0.54.
| Revenue | 8.26M |
| Gross Profit | -674.84M |
| Operating Income | -1.27B |
| Pretax Income | -264.58M |
| Net Income | -299.77M |
| EBITDA | -1.26B |
| EBIT | -1.27B |
| Loss Per Share | -$0.54 |
Full Income Statement Balance Sheet
The company has $4.53 billion in cash and $108.94 million in debt, with a net cash position of $4.42 billion or $6.18 per share.
| Cash & Cash Equivalents | 4.53B |
| Total Debt | 108.94M |
| Net Cash | 4.42B |
| Net Cash Per Share | $6.18 |
| Equity (Book Value) | 4.97B |
| Book Value Per Share | 6.02 |
| Working Capital | n/a |
Full Balance Sheet Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 3.61M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | -15,353.57% |
| Pretax Margin | -3,203.12% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ROIV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.35% |
| Shareholder Yield | 4.35% |
| Earnings Yield | -1.29% |
| FCF Yield | n/a |
Dividend Details Analyst Forecast
The average price target for ROIV is $37.04, which is 13.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $37.04 |
| Price Target Difference | 13.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 166.33% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |